Fernando Gallay

Fernando Gallay is a seasoned professional in the pharmaceutical industry with extensive experience in marketing and business management. Currently serving as a Senior Business Unit Manager at Amgen since December 2024, Gallay previously held the position of Breast Cancer Marketing Lead at Novartis from March 2023 to December 2024, where commercial vision and strategy were developed to enhance the Breast Cancer franchise in Argentina. Gallay's earlier roles at Amgen included Hematology Marketing Manager, responsible for leading the Hematology franchise, and Sr Associate Marketing Oncology & Hematology, where notable achievements included launching the first biosimilar of Trastuzumab in the Argentine market. Prior experience at Pierre Fabre Group encompassed roles as Product Manager and in various marketing and commercial analyst positions. Gallay holds a Diploma of Education in Health Economics from Universidad de 'San Andrés'.